MedTrace Logo

Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction

NCT00882739 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2012-01-26

No results posted yet for this study

Summary

The aim of this study is to determine both safety and effectiveness of three different loading dose regimens of clopidogrel in patients with acute myocardial infarction undergoing primary angioplasty.

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

Clopidogrel 300 mg

Patients will receive a 300 mg clopidogrel loading dose in the cath-lab setting

DRUG

Clopidogrel 600 mg

Patients will receive a 600 mg clopidogrel loading dose at first medical contact

DRUG

Clopidogrel 900 mg

Patients will receive a 900 mg clopidogrel loading dose at first medical contact

Sponsors & Collaborators

  • Ospedale San Donato

    lead OTHER

Principal Investigators

  • Leonardo Bolognese, MD, FESC · Ospedale San Donato

  • Kenneth Ducci, MD · Ospedale San Donato

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00882739 on ClinicalTrials.gov